The isothiocyanate erucin abrogates telomerase in hepatocellular carcinoma cells in vitro and in an orthotopic xenograft tumour model of HCC
Open Access
- 25 September 2014
- journal article
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 18 (12) , 2393-2403
Abstract
In contrast to cancer cells, most normal human cells have no or low telomerase levels which makes it an attractive target for anti‐cancer drugs. The small molecule sulforaphane from broccoli is known for its cancer therapeutic potential in vitro and in vivo. In animals and humans it was found to be quickly metabolized into 4‐methylthiobutyl isothiocyanate (MTBITC, erucin) which we recently identified as strong selective apoptosis inducer in hepatocellular carcinoma (HCC) cells. Here, we investigated the relevance of telomerase abrogation for cytotoxic efficacy of MTBITC against HCC. The drug was effective against telomerase, independent from TP53 and MTBITC also blocked telomerase in chemoresistant subpopulations. By using an orthotopic human liver cancer xenograft model, we give first evidence that MTBITC at 50 mg/KG b.w./d significantly decreased telomerase activity in vivo without affecting enzyme activity of adjacent normal tissue. Upon drug exposure, telomerase decrease was consistent with a dose‐dependent switch to anti‐survival, cell arrest and apoptosis in our in vitro HCC models. Blocking telomerase by the specific inhibitor TMPyP4 further sensitized cancer cells to MTBITC‐mediated cytotoxicity. Overexpression of hTERT, but not enzyme activity deficient DNhTERT, protected against apoptosis; neither DNA damage nor cytostasis induction by MTBITC was prevented by hTERT overexpression. These findings imply that telomerase enzyme activity does not protect against MTBITC‐induced DNA damage but impacts signalling processes upstream of apoptosis execution level.Keywords
Funding Information
- Open Access Publication Fund of the Albert Ludwigs University Freiburg
This publication has 42 references indexed in Scilit:
- Exploring the effects of isothiocyanates on chemotherapeutic drugsExpert Opinion on Drug Metabolism & Toxicology, 2013
- 3-Nitrobenzanthrone (3-NBA) induced micronucleus formation and DNA damage in human hepatoma (HepG2) cellsToxicology Letters, 2004
- Loss of p53 function accelerates acquisition of telomerase activity in indefinite lifespan human mammary epithelial cell linesOncogene, 2003
- Decision making by p53: life, death and cancerCell Death & Differentiation, 2003
- Massive Telomere Loss Is an Early Event of DNA Damage-induced ApoptosisJournal of Biological Chemistry, 2003
- Telomerase Expression and p53 Status in Hepatocellular CarcinomaAmerican Journal of Gastroenterology, 2002
- TERT regulates cell survival independent of telomerase enzymatic activityOncogene, 2002
- Telomerase overexpression in K562 leukemia cells protects against apoptosis by serum deprivation and double-stranded DNA break inducing agents, but not against DNA synthesis inhibitorsCancer Letters, 2002
- Telomere states and cell fatesNature, 2000
- DNA Damage-Induced Activation of p53 by the Checkpoint Kinase Chk2Science, 2000